+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Probiotics Market by Ingredient, Function, Application, and End User: Global Opportunity Analysis and Industry Forecast 2021-2030

  • PDF Icon

    Report

  • 302 Pages
  • October 2021
  • Region: Global
  • Allied Market Research
  • ID: 5521540
Description Jump to:
The global probiotics market size was valued at $34.1 billion in 2020, and is projected to reach $73.9 billion by 2030, registering a CAGR of 8.6%



Probiotics are made up of good live bacteria and/or yeasts that exist naturally in the body. A body contains both good and bad bacteria. When a person gets an infection, more bad bacteria enter the body, throwing the body system out of whack. Good bacteria aids in the elimination of excessive bad bacteria, restoring balance. Probiotic supplements are a way to increase the number of good bacteria in the body.

Probiotics have beneficial effects on the human body when consumed in sufficient quantities, such as improved gut health and decreased intestinal inflammation. Probiotics play an important role in preventive healthcare as they strengthen the immune system, which prevents diseases from occurring. As a result, rise in awareness of preventive healthcare is expected to benefit overall market growth.

A healthy lifestyle and dietary choices that aid in disease prevention are examples of preventive healthcare. Preventive healthcare awareness has grown as a result of a variety of factors, including surge in disposable income, rise in living standards, and an increase in the number of the elderly. In addition, the ease of access to information about preventive healthcare on the internet has helped to raise awareness.

Regulations regarding the use of probiotics in nutraceuticals, nutraceutical cosmetics, and dietary supplements, particularly infant formulas, are extremely stringent in some regions and are expected to pose a challenge to market players.

The COVID-19 pandemic had a positive impact on probiotics market. Some of the probiotics products and ingredient are used to enhance immunity in the body. Many market players had invested large amount of money on the new versions of probiotics products.

The probiotics market is segmented on the basis of ingredient, function, application, end user, and region. On the basis of ingredient, the market is categorized intobacteria and yeast. On the basis of function, the probiotics market is segmented into regular, preventative healthcare, and therapeutic. As per application, it is divided into food & beverage, dietary supplement, and animal feed.

According to end user, the probiotics market is fragmented into human and animal. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, France, the Netherlands, Germany, Turkey, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, the UAE, and the rest of LAMEA).

As a result of global players' competitive strategies, Asia-Pacific has seen a significant increase in consumer awareness. Strong demand from countries such as India, China, and Australia has contributed to overall growth. The increase in population, combined with rise in disposable income and standard of living, is expected to contribute to overall growth.

The factors such as rapid growth in the food & beverage industry in developing countries, such as India and China, and rise inawareness of the benefits of probiotic food products drive the market.The major players operating in the global probiotics market are BioGaia AB, Danone, Chr. Hansen Holding A/S, Yakult Honsha Co. Ltd., Probi AB, Lifeway Foods, Inc., Nestle S.A., Ganeden, Inc., E. I. du Pont de Nemours and Company, and Protexin.

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of current trends, estimations, and dynamics of the global probiotics market from 2021 to 2030 to identify the prevailing market opportunities.
  • Porter’s five forces analysis highlights the potency of the buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global industry. The market player positioning segment facilitates benchmarking while providing a clear understanding of the present position of the key market players.
  • The report includes analysis of the regional as well as global market, key players, market segments, application areas, and growth strategies.

KEY MARKET Segments


By Ingredient

  • Bacteria
  • Yeast

By Function

  • Regular
  • Preventative Healthcare
  • Therapeutic

By Application

  • Food & Beverage
  • Dietary Supplements
  • Animal Feed

By End User

  • Human
  • Animal

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • France
  • Netherlands
  • Germany
  • Turkey
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • UAE
  • Rest of LAMEA

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market share analysis/top player positioning, 2020
3.5. Top impacting factors
3.5.1. Growing health concerns
3.5.2. Low awareness among consumers
3.5.3. Increasing investment on R&D
3.5.4. Stringent government regulations
3.5.5. Rising consumption of functional foods
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Growing health concerns
3.6.1.2. Rising consumption of functional foods
3.6.1.3. Increasing investment in Research & Development
3.6.2. Restraints
3.6.2.1. Government regulations
3.6.2.2. Low awareness level among consumers about effectiveness of probiotic products
3.6.3. Opportunities
3.6.3.1. Rising demand of probiotic products in developing nations
3.6.3.2. Creating awareness about the benefits of probiotics
3.7. Impact of COVID-19
3.8. Value chain analysis
3.8.1. Research and Development:
3.8.2. Raw material supplier:
3.8.3. Production:
3.8.4. Commercialization:
3.8.5. End Users:
CHAPTER 4: PROBIOTICS MARKET, BY INGREDIENTS
4.1. Overview
4.1.1. Market size and forecast
4.2. Bacteria
4.2.1. Overview
4.2.2. Key market trends, growth factors, and opportunities
4.2.3. Market size and forecast
4.3. Yeast
4.3.1. Overview
4.3.2. Key market trends, growth factors, and opportunities
4.3.3. Market size and forecast
CHAPTER 5: PROBIOTICS MARKET, BY FUNCTION
5.1. Overview
5.1.1. Market size and forecast
5.2. Regular
5.2.1. Overview
5.2.2. Key market trends, growth factors, and opportunities
5.2.3. Market size and forecast
5.3. Preventative healthcare
5.3.1. Overview
5.3.2. Key market trends, growth factors, and opportunities
5.3.3. Market size and forecast
5.4. Therapeutic
5.4.1. Overview
5.4.2. Key market trends, growth factors, and opportunities
5.4.3. Market size and forecast
CHAPTER 6: PROBIOTICS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Food & beverage
6.2.1. Overview
6.2.2. Key market trends, growth factors, and opportunities
6.2.3. Market size and forecast
6.3. Dietary supplements
6.3.1. Overview
6.3.2. Key market trends, growth factors, and opportunities
6.3.3. Market size and forecast
6.4. Animal feed
6.4.1. Overview
6.4.2. Key market trends, growth factors, and opportunities
6.4.3. Market size and forecast
CHAPTER 7: PROBIOTICS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Human
7.2.1. Overview
7.2.2. Key market trends, growth factors, and opportunities
7.2.3. Market size and forecast
7.3. Animal
7.3.1. Overview
7.3.2. Key market trends, growth factors, and opportunities
7.3.3. Market size and forecast
CHAPTER 8: PROBIOTICS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Overview
8.2.2. Key market trends, growth factors, and opportunities
8.2.3. Market size and forecast, by ingredients
8.2.4. Market size and forecast, by function
8.2.5. Market size and forecast, by application
8.2.6. Market size and forecast, by end user
8.2.7. Market size and forecast, by country
8.2.7.1. U.S.
8.2.7.1.1. Market size and forecast, by ingredients
8.2.7.1.2. Market size and forecast, by function
8.2.7.1.3. Market size and forecast, by application
8.2.7.1.4. Market size and forecast, by end user
8.2.7.2. Canada
8.2.7.2.1. Market size and forecast, by ingredients
8.2.7.2.2. Market size and forecast, by function
8.2.7.2.3. Market size and forecast, by application
8.2.7.2.4. Market size and forecast, by end user
8.2.7.3. Mexico
8.2.7.3.1. Market size and forecast, by ingredients
8.2.7.3.2. Market size and forecast, by function
8.2.7.3.3. Market size and forecast, by application
8.2.7.3.4. Market size and forecast, by end user
8.3. Europe
8.3.1. Overview
8.3.2. Key market trends, growth factors, and opportunities
8.3.3. Market size and forecast, by ingredients
8.3.4. Market size and forecast, by function
8.3.5. Market size and forecast, by application
8.3.6. Market size and forecast, by end user
8.3.7. Market size and forecast, by country
8.3.7.1. UK
8.3.7.1.1. Market size and forecast, by ingredients
8.3.7.1.2. Market size and forecast, by function
8.3.7.1.3. Market size and forecast, by application
8.3.7.1.4. Market size and forecast, by end user
8.3.7.2. France
8.3.7.2.1. Market size and forecast, by ingredients
8.3.7.2.2. Market size and forecast, by function
8.3.7.2.3. Market size and forecast, by application
8.3.7.2.4. Market size and forecast, by end user
8.3.7.3. The Netherlands
8.3.7.3.1. Market size and forecast, by ingredients
8.3.7.3.2. Market size and forecast, by function
8.3.7.3.3. Market size and forecast, by application
8.3.7.3.4. Market size and forecast, by end user
8.3.7.4. Germany
8.3.7.4.1. Market size and forecast, by ingredients
8.3.7.4.2. Market size and forecast, by function
8.3.7.4.3. Market size and forecast, by application
8.3.7.4.4. Market size and forecast, by end user
8.3.7.5. Turkey
8.3.7.5.1. Market size and forecast, by ingredients
8.3.7.5.2. Market size and forecast, by function
8.3.7.5.3. Market size and forecast, by application
8.3.7.5.4. Market size and forecast, by end user
8.3.7.6. Rest of Europe
8.3.7.6.1. Market size and forecast, by ingredients
8.3.7.6.2. Market size and forecast, by function
8.3.7.6.3. Market size and forecast, by application
8.3.7.6.4. Market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Key market trends, growth factors, and opportunities
8.4.3. Market size and forecast, by ingredients
8.4.4. Market size and forecast, by function
8.4.5. Market size and forecast, by application
8.4.6. Market size and forecast, by end user
8.4.7. Market size and forecast, by country
8.4.7.1. China
8.4.7.1.1. Market size and forecast, by ingredients
8.4.7.1.2. Market size and forecast, by function
8.4.7.1.3. Market size and forecast, by application
8.4.7.1.4. Market size and forecast, by end user
8.4.7.2. Japan
8.4.7.2.1. Market size and forecast, by ingredients
8.4.7.2.2. Market size and forecast, by function
8.4.7.2.3. Market size and forecast, by application
8.4.7.2.4. Market size and forecast, by end user
8.4.7.3. India
8.4.7.3.1. Market size and forecast, by ingredients
8.4.7.3.2. Market size and forecast, by function
8.4.7.3.3. Market size and forecast, by application
8.4.7.3.4. Market size and forecast, by end user
8.4.7.4. South Korea
8.4.7.4.1. Market size and forecast, by ingredients
8.4.7.4.2. Market size and forecast, by function
8.4.7.4.3. Market size and forecast, by application
8.4.7.4.4. Market size and forecast, by end user
8.4.7.5. Australia
8.4.7.5.1. Market size and forecast, by ingredients
8.4.7.5.2. Market size and forecast, by function
8.4.7.5.3. Market size and forecast, by application
8.4.7.5.4. Market size and forecast, by end user
8.4.7.6. Rest of Asia-Pacific
8.4.7.6.1. Market size and forecast, by ingredients
8.4.7.6.2. Market size and forecast, by function
8.4.7.6.3. Market size and forecast, by application
8.4.7.6.4. Market size and forecast, by end user
8.5. LAMEA
8.5.1. Overview
8.5.2. Key market trends, growth factors, and opportunities
8.5.3. Market size and forecast, by ingredients
8.5.4. Market size and forecast, by function
8.5.5. Market size and forecast, by application
8.5.6. Market size and forecast, by end user
8.5.7. Market size and forecast, by country
8.5.7.1. Brazil
8.5.7.1.1. Market size and forecast, by ingredients
8.5.7.1.2. Market size and forecast, by function
8.5.7.1.3. Market size and forecast, by application
8.5.7.1.4. Market size and forecast, by end user
8.5.7.2. South Africa
8.5.7.2.1. Market size and forecast, by ingredients
8.5.7.2.2. Market size and forecast, by function
8.5.7.2.3. Market size and forecast, by application
8.5.7.2.4. Market size and forecast, by end user
8.5.7.3. United Arab Emirates
8.5.7.3.1. Market size and forecast, by ingredients
8.5.7.3.2. Market size and forecast, by function
8.5.7.3.3. Market size and forecast, by application
8.5.7.3.4. Market size and forecast, by end user
8.5.7.4. Rest of LAMEA
8.5.7.4.1. Market size and forecast, by ingredients
8.5.7.4.2. Market size and forecast, by function
8.5.7.4.3. Market size and forecast, by application
8.5.7.4.4. Market size and forecast, by end user
CHAPTER 9: COMPETITION LANDSCAPE
9.1. Top winning strategies
9.2. Product mapping
9.3. Competitive dashboard
9.4. Competitive heat map
9.5. Key developments
9.5.1. Acquisition
9.5.2. Business Expansion
9.5.3. Product Launch
CHAPTER 10: COMPANY PROFILES
10.1. Archer-Daniels-Midland Company
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. R&D Expenditure
10.1.7. Business performance
10.1.8. Key strategic moves and developments
10.2. BioGaia AB
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. R&D Expenditure
10.2.7. Business performance
10.2.8. Key strategic moves and developments
10.3. Chr. Hansen Holding A/S
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. R&D Expenditure
10.3.7. Business performance
10.3.8. Key strategic moves and developments
10.4. Danone
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Product portfolio
10.4.5. Business performance
10.5. Deerland Probiotics & Enzymes Inc.
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Product portfolio
10.5.5. Key strategic moves and developments
10.6. Lallemand Inc.
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Product portfolio
10.6.5. Key strategic moves and developments
10.7. Nestlé S.A
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. R&D Expenditure
10.7.7. Business performance
10.7.8. Key strategic moves and developments
10.8. Probi AB
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. R&D Expenditure
10.8.7. Business performance
10.8.8. Key strategic moves and developments
10.9. Probiotical S.P.A.
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Product portfolio
10.10. Yakult Honsha Co. Ltd
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. R&D Expenditure
10.10.7. Business performance
10.10.8. Key strategic moves and developments
List of Tables
TABLE 01. GLOBAL PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 02. PROBIOTICS MARKET REVENUE FOR BACTERIA, BY REGION, 2020-2030 ($BILLION)
TABLE 03. PROBIOTICS MARKET REVENUE FOR YEAST, BY REGION, 2020-2030 ($BILLION)
TABLE 04. GLOBAL PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 05. PROBIOTICS MARKET REVENUE FOR REGULAR, BY REGION, 2020-2030 ($BILLION)
TABLE 06. PROBIOTICS MARKET REVENUE FOR PREVENTATIVE HEALTHCARE, BY REGION, 2020-2030 ($BILLION)
TABLE 07. PROBIOTICS MARKET REVENUE FOR THERAPEUTIC, BY REGION, 2020-2030 ($BILLION)
TABLE 08. GLOBAL PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 09. PROBIOTICS MARKET REVENUE FOR FOOD & BEVERAGE, BY REGION, 2020-2030 ($BILLION)
TABLE 10. PROBIOTICS MARKET REVENUE FOR DIETARY SUPPLEMENTS, BY REGION, 2020-2030 ($BILLION)
TABLE 11. PROBIOTICS MARKET REVENUE FOR ANIMAL FEED, BY REGION, 2020-2030 ($BILLION)
TABLE 12. PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 13. PROBIOTICS MARKET REVENUE FOR HUMAN, BY REGION, 2020-2030 ($BILLION)
TABLE 14. PROBIOTICS MARKET REVENUE FOR ANIMAL, BY REGION, 2020-2030 ($BILLION)
TABLE 15. PROBIOTICS MARKET, BY REGION, 2020-2030 ($BILLION)
TABLE 16. NORTH AMERICA PROBIOTICS MARKET, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 17. NORTH AMERICA PROBIOTICS MARKET, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 18. NORTH AMERICA PROBIOTICS MARKET, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 19. NORTH AMERICA PROBIOTICS MARKET, BY END USER, 2020-2030 ($BILLION)
TABLE 20. NORTH AMERICA PROBIOTICS MARKET REVENUE, BY COUNTRY, 2020-2030 ($BILLION)
TABLE 21. U.S. PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 22. U.S. PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 23. U.S. PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 24. U.S. PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 25. CANADA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 26. CANADA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 27. CANADA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 28. CANADA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 29. MEXICO PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 30. MEXICO PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 31. MEXICO PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 32. MEXICO PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 33. EUROPE PROBIOTICS MARKET, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 34. EUROPE PROBIOTICS MARKET, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 35. EUROPE PROBIOTICS MARKET, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 36. EUROPE PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 37. EUROPE PROBIOTICS MARKET REVENUE, BY COUNTRY, 2020-2030 ($BILLION)
TABLE 38. UK PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 39. UK PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 40. UK PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 41. UK PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 42. FRANCE PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 43. FRANCE PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 44. FRANCE PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 45. FRANCE PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 46. THE NETHERLANDS PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 47. THE NETHERLANDS PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 48. THE NETHERLANDS PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 49. THE NETHERLANDS PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 50. GERMANY PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 51. GERMANY PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 52. GERMANY PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 53. GERMANY PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 54. TURKEY PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 55. TURKEY PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 56. TURKEY PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 57. TURKEY PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 58. REST OF EUROPE PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 59. REST OF EUROPE PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 60. REST OF EUROPE PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 61. REST OF EUROPE PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 62. ASIA-PACIFIC PROBIOTICS MARKET, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 63. ASIA-PACIFIC PROBIOTICS MARKET, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 64. ASIA-PACIFIC PROBIOTICS MARKET, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 65. ASIA-PACIFIC PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 66. ASIA-PACIFIC PROBIOTICS MARKET REVENUE, BY COUNTRY, 2020-2030 ($BILLION)
TABLE 67. CHINA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 68. CHINA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 69. CHINA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 70. CHINA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 71. JAPAN PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 72. JAPAN PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 73. JAPAN PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 74. JAPAN PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 75. INDIA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 76. INDIA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 77. INDIA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 78. INDIA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 79. SOUTH KOREA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 80. SOUTH KOREA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 81. SOUTH KOREA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 82. SOUTH KOREA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 83. AUSTRALIA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 84. AUSTRALIA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 85. AUSTRALIA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 86. AUSTRALIA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 87. REST OF ASIA-PACIFIC PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 88. REST OF ASIA-PACIFIC PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 89. REST OF ASIA-PACIFIC PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 90. REST OF ASIA-PACIFIC PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 91. LAMEA PROBIOTICS MARKET, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 92. LAMEA PROBIOTICS MARKET, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 93. LAMEA PROBIOTICS MARKET, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 94. LAMEA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 95. LAMEA PROBIOTICS MARKET REVENUE, BY COUNTRY, 2020-2030 ($BILLION)
TABLE 96. BRAZIL PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 97. BRAZIL PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 98. BRAZIL PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 99. BRAZIL PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 100. SOUTH AFRICA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 101. SOUTH AFRICA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 102. SOUTH AFRICA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 103. SOUTH AFRICA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 104. UNITED ARAB EMIRATES PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 105. UNITED ARAB EMIRATES PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 106. UNITED ARAB EMIRATES PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 107. UNITED ARAB EMIRATES PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 108. REST OF LAMEA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
TABLE 109. REST OF LAMEA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
TABLE 110. REST OF LAMEA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
TABLE 111. REST OF LAMEA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
TABLE 112. ARCHER-DANIELS-MIDLAND COMPANY: KEY EXECUTIVES
TABLE 113. ARCHER-DANIELS-MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 114. ARCHER-DANIELS-MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 115. ARCHER-DANIELS-MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 116. ARCHER-DANIELS-MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 117. ARCHER-DANIELS-MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
TABLE 118. BIOGAIA AB: KEY EXECUTIVES
TABLE 119. BIOGAIA AB: COMPANY SNAPSHOT
TABLE 120. BIOGAIA AB: OPERATING SEGMENTS
TABLE 121. BIOGAIA AB: PRODUCT PORTFOLIO
TABLE 122. BIOGAIA AB: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 123. BIOGAIA AB: NET SALES, 2018-2020 ($MILLION)
TABLE 124. CHR. HANSEN HOLDING A/S: KEY EXECUTIVES
TABLE 125. CHR. HANSEN HOLDING A/S: COMPANY SNAPSHOT
TABLE 126. CHR. HANSEN HOLDING A/S: OPERATING SEGMENTS
TABLE 127. CHR. HANSEN HOLDING A/S: PRODUCT PORTFOLIO
TABLE 128. CHR. HANSEN HOLDING A/S: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 129. CHR. HANSEN HOLDING A/S: NET SALES, 2018-2020 ($MILLION)
TABLE 130. DANONE: KEY EXECUTIVES
TABLE 131. DANONE: COMPANY SNAPSHOT
TABLE 132. DANONE: PRODUCT PORTFOLIO
TABLE 133. DANONE: NET SALES, 2018-2020 ($MILLION)
TABLE 134. DEERLAND PROBIOTICS & ENZYMES INC.: KEY EXECUTIVES
TABLE 135. DEERLAND PROBIOTICS & ENZYMES INC.: COMPANY SNAPSHOT
TABLE 136. DEERLAND PROBIOTICS & ENZYMES INC.: PRODUCT PORTFOLIO
TABLE 137. LALLEMAND INC.: KEY EXECUTIVES
TABLE 138. LALLEMAND INC.: COMPANY SNAPSHOT
TABLE 139. LALLEMAND INC.: PRODUCT PORTFOLIO
TABLE 140. NESTLÉ S.A.: KEY EXECUTIVES
TABLE 141. NESTLÉ S.A.: COMPANY SNAPSHOT
TABLE 142. NESTLÉ S.A.: OPERATING SEGMENTS
TABLE 143. NESTLÉ S.A.: PRODUCT PORTFOLIO
TABLE 144. NESTLÉ S.A.: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 145. NESTLÉ S.A.: NET SALES, 2018-2020 ($MILLION)
TABLE 146. PROBI AB: KEY EXECUTIVES
TABLE 147. PROBI AB: COMPANY SNAPSHOT
TABLE 148. PROBI AB: OPERATING SEGMENTS
TABLE 149. PROBI AB: PRODUCT PORTFOLIO
TABLE 150. PROBI AB: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 151. PROBI AB: NET SALES, 2018-2020 ($MILLION)
TABLE 152. PROBIOTICAL S.P.A.: KEY EXECUTIVES
TABLE 153. PROBIOTICAL S.P.A.: COMPANY SNAPSHOT
TABLE 154. PROBIOTICAL S.P.A.: PRODUCT PORTFOLIO
TABLE 155. YAKULT HONSHA CO., LTD.: KEY EXECUTIVES
TABLE 156. YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT
TABLE 157. YAKULT HONSHA CO., LTD.: OPERATING SEGMENTS
TABLE 158. YAKULT HONSHA CO., LTD.: PRODUCT PORTFOLIO
TABLE 159. YAKULT HONSHA CO., LTD.: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 160. YAKULT HONSHA CO., LTD.: NET SALES, 2018-2020 ($MILLION)
List of Figures
FIGURE 01. KEY MARKET SEGMENT
FIGURE 02. GLOBAL PROBIOTICS MARKET SNAPSHOT, 2020-2030
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTION
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 10. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2020
FIGURE 11. TOP IMPACTING FACTORS
FIGURE 12. PROBIOTICS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13. VALUE CHAIN ANALYSIS
FIGURE 14. PROBIOTICS MARKET, BY INGREDIENTS, 2020 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR BACTERIA, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR YEAST, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17. PROBIOTICS MARKET, BY FUNCTION, 2020 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR REGULAR, BY COUNTRY, 2020 & 2030 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR PREVENTATIVE HEALTHCARE, BY COUNTRY, 2020 & 2030 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR THERAPEUTIC, BY COUNTRY, 2020 & 2030 (%)
FIGURE 21. PROBIOTICS MARKET, BY APPLICATION, 2020 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR FOOD & BEVERAGE, BY COUNTRY, 2020 & 2030 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR ANIMAL FEED, BY COUNTRY, 2020 & 2030 (%)
FIGURE 25. PROBIOTICS MARKET, BY END USER, 2020 (%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR HUMAN, BY COUNTRY, 2020 & 2030 (%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR ANIMAL, BY COUNTRY, 2020 & 2030 (%)
FIGURE 28. PROBIOTICS MARKET, BY REGION, 2020 (%)
FIGURE 29. U.S. PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 30. CANADA PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 31. MEXICO PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 32. UK PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 33. FRANCE PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 34. THE NETHERLANDS PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 35. GERMANY PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 36. TURKEY PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 37. REST OF EUROPE PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 38. CHINA PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 39. JAPAN PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 40. INDIA PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 41. SOUTH KOREA PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 42. AUSTRALIA PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 43. REST OF ASIA-PACIFIC PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 44. BRAZIL PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 45. SOUTH AFRICA PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 46. UNITED ARAB EMIRATES PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 47. REST OF LAMEA PROBIOTICS MARKET, 2020-2030 ($BILLION)
FIGURE 48. TOP WINNING STRATEGIES, BY YEAR, 2018-2020*
FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2020* (%)
FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY, 2018-2020*
FIGURE 51. PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 52. COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 53. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 54. ARCHER-DANIELS-MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 55. ARCHER-DANIELS-MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
FIGURE 56. ARCHER-DANIELS-MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 57. ARCHER-DANIELS-MIDLAND COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 58. BIOGAIA AB: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 59. BIOGAIA AB: NET SALES, 2018-2020 ($MILLION)
FIGURE 60. BIOGAIA AB: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 61. BIOGAIA AB: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 62. CHR. HANSEN HOLDING A/S: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 63. CHR. HANSEN HOLDING A/S: NET SALES, 2018-2020 ($MILLION)
FIGURE 64. CHR. HANSEN HOLDING A/S: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 65. CHR. HANSEN HOLDING A/S: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 66. DANONE: NET SALES, 2018-2020 ($MILLION)
FIGURE 67. DANONE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 68. NESTLÉ S.A.: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 69. NESTLÉ S.A.: NET SALES, 2018-2020 ($MILLION)
FIGURE 70. NESTLÉ S.A.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 71. PROBI AB: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 72. PROBI AB: NET SALES, 2018-2020 ($MILLION)
FIGURE 73. PROBI AB: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 74. YAKULT HONSHA CO., LTD.: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 75. YAKULT HONSHA CO., LTD.: NET SALES, 2018-2020 ($MILLION)
FIGURE 76. YAKULT HONSHA CO., LTD.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 77. YAKULT HONSHA CO., LTD.: REVENUE SHARE BY REGION, 2020 (%)

Companies Mentioned

  • BioGaia AB
  • Danone
  • Chr. Hansen Holding A/S
  • Yakult Honsha Co. Ltd.
  • Probi AB
  • Lifeway Foods Inc.
  • Nestle S.A.
  • Ganeden Inc.
  • E. I. du Pont de Nemours and Company
  • Protexin

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages302
PublishedOctober 2021
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 34.1 billion
Forecasted Market Value ( USD ) by 2030 $ 73.9 billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Probiotics Market by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel and Region - Forecast to 2029 - Product Image

Probiotics Market by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel and Region - Forecast to 2029

  • Report
  • 342 Pages
  • Global
From
Probiotics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Probiotics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Probiotics Market - Focused Insights 2024-2029 - Product Image

Probiotics Market - Focused Insights 2024-2029

  • Report
  • 137 Pages
  • Global
From
Probiotics Market Size, Share & Trends Analysis Report By Product, By Ingredient (Bacteria, Yeast), By Distribution Channel, By End Use (Human Probiotics, Animal Probiotics), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Probiotics Market Size, Share & Trends Analysis Report By Product, By Ingredient (Bacteria, Yeast), By Distribution Channel, By End Use (Human Probiotics, Animal Probiotics), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Probiotics Market Size, Share & Trends Analysis Report By Ingredient (Bacteria, and Yeast), By Product, By End-use (Human, and Animal), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Probiotics Market Size, Share & Trends Analysis Report By Ingredient (Bacteria, and Yeast), By Product, By End-use (Human, and Animal), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 347 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.